Yunfang Su

China Academy of Chinese Medical Sciences — China

Medicine · Health Sciences

8h-index196citations17works2.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(6), Neuroinflammation and Neurodegeneration Mechanisms(4), Tryptophan and brain disorders(4), Metabolomics and Mass Spectrometry Studies(3), Gut microbiota and health(2)

Publications17 total

Mechanism of Atractylodis Rhizoma in improving cognitive dysfunction in Alzheimer's disease by regulating the cAMP/CREB/BDNF pathway
International Immunopharmacology·2025Open Access
Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation
Journal of Ethnopharmacology·2025
Ferulic acid derived from Huanshaodan improves cognitive deficits in Alzheimer's disease model through regulating APP proteolytic processing via downregulation of SIRT2 expression
Journal of Ethnopharmacology·2025
Discovery of Atractylenolide Derivatives as Novel LSD1 Inhibitors for the Treatment of Alzheimer’s Disease
Journal of Agricultural and Food Chemistry·2025· 2 cited
Metabolomic and microbial insights: Kai-Xin-San’s impact on Alzheimer’s disease pathology
iScience·2025Open Access
Integrated multi-omics analysis and experimental validation reveals the mechanism of tenuifoliside A activity in Alzheimer's disease
Journal of Ethnopharmacology·2025· 4 cited
Shenghui decoction inhibits neuronal cell apoptosis to improve Alzheimer's disease through the PDE4B/cAMP/CREB signaling pathway
Phytomedicine·2025· 5 cited
Proteomic analysis and experimental validation reveal the blood–brain barrier protective of Huanshaodan in the treatment of SAMP8 mouse model of Alzheimer’s disease
Chinese Medicine·2024· 2 citedOpen Access
Huanshaodan regulates microglial glucose metabolism reprogramming to alleviate neuroinflammation in AD mice through mTOR/HIF-1α signaling pathway
Frontiers in Pharmacology·2024· 9 citedOpen Access
Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer’s disease mice via suppressing TLR4 signaling pathway through the gut-brain axis
PLoS ONE·2023· 21 citedOpen Access
Radix Rehmanniae Praeparata (Shu Dihuang) exerts neuroprotective effects on ICV-STZ-induced Alzheimer’s disease mice through modulation of INSR/IRS-1/AKT/GSK-3β signaling pathway and intestinal microbiota
Frontiers in Pharmacology·2023· 27 citedOpen Access
LiuweiDihuang improved cognitive functions in SAMP8 mice by inhibiting COX-2 expression and subsequent neuroinflammation
Journal of Ethnopharmacology·2022· 17 cited
Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models
European Journal of Pharmacology·2022· 36 cited
Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model
Frontiers in Neuroscience·2022· 25 citedOpen Access
Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia
Journal of Ethnopharmacology·2022· 27 cited
A GLP-2 Analogue Protects SH-SY5Y and Neuro-2a Cells Against Mitochondrial Damage, Autophagy Impairments and Apoptosis in a Parkinson Model
Drug Research·2020· 21 citedOpen Access
Systemic theory of Shaoyang, Sanjiao and Moyuan.
Zhonghua zhongyiyao zazhi·2010

Frequent Co-authors

Zhenqiang Zhang(16), Junying Song(9), Jinlian Ma(8), Zhishen Xie(8), Pan Wang(7), Huifen Ma(7), Zhonghua Li(6), Ningning Liu(4), Zijuan Zhang(4), Yiran Sun(4), Christian Hölscher(3), Ruiqin Sun(3), Huifen Ma(3), Congcong Shang(3), Pan Wang(3), Hao Li(2), Ye Yuan(2), Ming Shi(2), Gai Gao(2), Jiangyan Xu(2)